During the past decade, Clinique Hartmann conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Hartmann" #1 sponsor was "UNICANCER" with 5 trials, followed by "ARCAGY/ GINECO GROUP" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Hartmann" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Grupo Espanol de Investigacion del Cancer de Mama" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Hartmann" are "Breast Cancer" (8 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials), "Ovarian Neoplasms" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Clinique Hartmann" in a lesser frequency.

Most popular intervention types in "Clinique Hartmann" are "Drug" (18 trials), "Radiation" (6 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (4 trials), "Trastuzumab" (3 trials), "cisplatin" (3 trials), "radiation therapy" (3 trials) and "AMG 479" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Hartmann" are 13 trials for "Female" genders, 10 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Hartmann". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Clinique Hartmann, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Hartmann, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".